Back
Adaptimmune Therapeutics PLC Stock Price Chart
Sponsored
ADAP
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
18
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.99
Seasonality Move:
-36.59%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.06 | Sell |
20-day SMA: | 1.14 | Sell |
50-day SMA: | 1.16 | Sell |
200-day SMA: | 1.1 | Sell |
8-day EMA: | 1.05 | Sell |
20-day EMA: | 1.1 | Sell |
50-day EMA: | 1.12 | Sell |
200-day EMA: | 1.1 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 37.11 | Sell |
Chaikin Money Flow: | -298062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.04 - 1.22) | Sell |
Bollinger Bands (100): | (0.99 - 1.23) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.00 while ADAP 8-day simple moving average is 1.06, which is a Sell signal.
- The stock price of ADAP is 1.00 while Adaptimmune Therapeutics PLC 20-day SMA is 1.14, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day simple moving average is 1.16 while ADAP share price is 1.00, making it a Sell technically.
- ADAP stock price is 1.00 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.10, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
18
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a Sell
The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.00. The Score for ADAP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
254.75M
Price in USD:
1.00
Share Volume:
837.25K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.42
Sell
18
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?
The Adaptimmune Therapeutics PLC stock price is 1.00 USD today. -
Will ADAP stock go up or go down?
Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptimmune Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 1.00 while ADAP 8-day exponential moving average is 1.05, which is a Sell signal.
- The stock price of ADAP is 1.00 while Adaptimmune Therapeutics PLC 20-day EMA is 1.10, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day exponential moving average is 1.12 while ADAP share price is 1.00, making it a Sell technically.
- ADAP stock price is 1.00 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.10, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
- ADAP Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Adaptimmune Therapeutics PLC is a Sell
- Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 37.11, which suggest Adaptimmune Therapeutics PLC is oversold
- The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (1.04 - 1.22), which suggest Adaptimmune Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.99 - 1.23), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.